Latest News

Our latest research, company updates and industry insight

Stephen’s Secondment Boosts Technology Development

ClearSky’s co-founder and director Professor Stephen Smith was recently awarded a secondment to evaluate the technology for measuring the symptoms of Parkinson’s. Professor Stephen Smith, Deputy Head of the Department of Electronic Engineering at the University of...

read more

What is levodopa-induced dyskinesia?

Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine. People with Parkinson’s lack enough dopamine because some of the brain cells that make it have died. The loss of...

read more

What are evolutionary algorithms?

Evolutionary algorithms are inspired by the biological model of evolution and natural selection proposed by Darwin. We have used evolutionary algorithms to recognise movement characteristics of Parkinson’s.

read more

Dr Smith invited to speak at Parkinson’s UK events

Dr Stephen Smith will be a speaker at the sell-out Parkinson’s UK 2017 Research Support Network Conference in Birmingham in October. The conference provides people affected by Parkinson's the ideal opportunity to learn more about the work supported by Parkinson’s UK –...

read more

ClearSky is heading to MEDICA 2017

ClearSky Medical Diagnostics is looking forward to attending and exhibiting at MEDICA 2017, the international medical trade fair. MEDICA is the world’s largest event for the medical sector – more than 128,000 international trade visitors from 70 countries attended the...

read more